Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CK.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.8.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ED.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BU.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCGNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DT.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCANSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.77 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.10.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EF.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.23.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.64NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.68NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.65 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.466NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
L.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.339NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.229NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.415NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.370NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.421NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.428.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.612NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.305NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.32.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBLNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.466.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used